Pacira Pharmaceuticals (PCRX)

Add to Watchlists Create an Alert
105.53 +2.37  +2.30% NASDAQ Sep 18, 3:46PM BATS Real time Currency in USD

Pacira Pharmaceuticals Enterprise Value:

3.640B for Sept. 17, 2014

View 4,000+ financial data types

View Full Chart

Pacira Pharmaceuticals Enterprise Value Chart

Export Data
Save Image

Pacira Pharmaceuticals Historical Enterprise Value Data

View and export this data going back to 2011. Start your YCharts Lite Membership
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Sept. 17, 2014 3.640B
Sept. 16, 2014 3.593B
Sept. 15, 2014 3.512B
Sept. 12, 2014 3.678B
Sept. 11, 2014 3.642B
Sept. 10, 2014 3.629B
Sept. 9, 2014 3.611B
Sept. 8, 2014 3.675B
Sept. 5, 2014 3.611B
Sept. 4, 2014 3.571B
Sept. 3, 2014 3.671B
Sept. 2, 2014 3.822B
Aug. 29, 2014 3.823B
Aug. 28, 2014 3.806B
Aug. 26, 2014 3.803B
Aug. 25, 2014 3.797B
Aug. 22, 2014 3.696B
Aug. 21, 2014 3.634B
Aug. 20, 2014 3.685B
Aug. 19, 2014 3.725B
Aug. 18, 2014 3.710B
Aug. 15, 2014 3.634B
Aug. 14, 2014 3.651B
Aug. 13, 2014 3.643B
Aug. 12, 2014 3.602B
   
Aug. 11, 2014 3.560B
Aug. 8, 2014 3.567B
Aug. 7, 2014 3.511B
Aug. 6, 2014 3.460B
Aug. 5, 2014 3.412B
Aug. 4, 2014 3.361B
Aug. 1, 2014 3.380B
July 31, 2014 3.239B
July 30, 2014 3.090B
July 29, 2014 3.072B
July 28, 2014 3.023B
July 25, 2014 3.007B
July 24, 2014 3.045B
July 23, 2014 3.038B
July 22, 2014 3.042B
July 21, 2014 3.013B
July 18, 2014 2.990B
July 17, 2014 2.923B
July 16, 2014 2.988B
July 15, 2014 3.028B
July 14, 2014 3.099B
July 11, 2014 3.036B
July 10, 2014 3.002B
July 9, 2014 2.965B
July 8, 2014 2.953B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Get data for
Advertisement

PCRX Enterprise Value Benchmarks

Companies
AstraZeneca 96.83B
Bristol-Myers Squibb 84.97B
Intercept Pharmaceuticals 5.450B

PCRX Enterprise Value Range, Past 5 Years

Minimum 85.58M Apr 14 2011
Maximum 3.823B Aug 29 2014
Average 1.008B

PCRX Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("PCRX", "enterprise_value")
  • Last 5 data points: =YCS("PCRX", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.